Chemical Structure : BMS-986458
CAS No.: 3005272-36-3
货号: PC-24668Not For Human Use, Lab Use Only.
BMS-986458 is a potent, highly selective, orally bioavailable CRL4 CRBN E3 ubiquitin ligase-dependent BCL6 ligand directed degrader with CRBN binding IC50 of 41 nM, and BCL-6 degradation of 0.2 nM in OCI-LY-1 cells (2 h).
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BMS-986458 is a potent, highly selective, orally bioavailable CRL4 CRBN E3 ubiquitin ligase-dependent BCL6 ligand directed degrader with CRBN binding IC50 of 41 nM, and BCL-6 degradation of 0.2 nM in OCI-LY-1 cells (2 h).
BMS-986458 demonstrates an exquisite selectivity for BCL6 degradation. In a panel of known CRBN neosubstrate assays, no degradation of CK1α, GSPT1, IKZF1, IZKF3, nor SALL4.
BMS-986458 potently exhibits antiproliferative effect against OCI-LY-1 cells with GI50 of 1.2 nM.
BMS-986458 rapidly degrades BCL6 protein to levels that drive broad anti-tumor effects in 80% of BCL6 expressing NHL cell lines and all ex vivo patient derived xenograft (PDX) models evaluated.
| 分子量 | 628.13 | |
| 分子式 | C32H34ClN9O3 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
2,6-Piperidinedione, 3-[6-[[(3R,4R)-1-[5-chloro-4-[(2,3-dihydro-1-methyl-2-oxo-1H-indol-5-yl)amino]-2-pyrimidinyl]-3-methyl-4-piperidinyl]amino]-1-methyl-1H-indazol-3-yl]- |
|
1. Lynda Groocock, et al. Blood. Volume 144, Supplement 1, 5 November 2024, Page 957.
2. Patent WO2023212147 A1.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright